MedMira Attends FDA Public Workshop as Interest in its Multiplex Rapid Tests Continues to Increase

Participation in this workshop is particularly timely, as MedMira advances a new multiplex rapid test for the simultaneous detection of HIV and Hepatitis B and C towards clinical trials and the FDA approval process under a Army Medical Research Acquisition Activity contract.

http://www.newswire.ca/en/story/1144251/medmira-attends-fda-public-workshop-as-interest-in-its-multiplex-rapid-tests-continues-to-increase